Translation. Region: Russian Federal
Source: People’s Republic of China in Russian – People’s Republic of China in Russian –
Source: People’s Republic of China – State Council News
BEIJING, June 4 (Xinhua) — China’s National Medical Products Administration has approved the first domestically developed nonavalent vaccine against human papillomavirus (HPV), the agency said in a statement Wednesday.
The move would end more than a decade of foreign drug dominance in China’s market.
The vaccine, which targets nine strains of HPV, is the second of its kind in the world. HPV vaccines are widely used to prevent cervical cancer in women, as well as genital cancers and warts in both men and women. -0-